Improving Risk Stratification and Identifying High-Cost Members

By Sumona Bose

January 20, 2024

Introduction

In a groundbreaking study, researchers have found that a risk prediction model using artificial intelligence (AI) can more accurately identify high-cost members in healthcare than traditional models. The study, conducted by a Medicaid accountable care organization, utilized AI to analyze multiple data sources, including claims data, demographics, social determinants of health (SDOH) data, and admission, discharge, and transfer (ADT) alerts. This article explores the avenues of which improving risk stratification contributes to healthcare.

Traditionally, risk stratification models have relied solely on demographic and claims information. However, this study demonstrated that incorporating AI and nontraditional data sources can significantly enhance the identification of high-cost members. The AI model, developed by Medical Home Network, consistently identified a higher proportion of the highest-spending members compared to the Chronic Illness and Disability Payment System (CDPS) model, which relied only on demographic and claims information.

To compare the models, researchers calculated mean, median, and total spending for members with the highest 5% of AI risk scores and compared these metrics with members identified by the CDPS model. The results showed that members deemed highest risk by the AI model had higher spending than those identified by the CDPS model.

Glancing at Risk Stratification

This innovative approach to risk stratification has significant implications for healthcare providers and payers. By accurately identifying high-cost members, healthcare organizations can allocate resources more effectively and develop targeted interventions to improve outcomes and reduce costs. Additionally, the incorporation of nontraditional data sources, such as SDOH and admission alerts, provides a more comprehensive understanding of patients’ health and social factors, enabling personalized and patient-centered care.

Discussing AI’s Reach in Healthcare

The use of AI in healthcare is not limited to risk stratification. AI is reconfiguring various aspects of healthcare, including diagnosis and treatment. For example, AI algorithms can analyze vast amounts of medical data, including electronic health records and medical images, to assist healthcare professionals in making accurate diagnoses and developing personalized treatment plans.

Furthermore, AI can help address healthcare disparities by ensuring equitable access to quality care. By analyzing large datasets, AI algorithms can identify patterns and trends that may be influenced by factors such as gender, race, or socioeconomic status. This information can inform policy and regulatory decisions to promote fairness and equality in healthcare.

Conclusion

As AI continues to advance, it is crucial for healthcare organizations to collaborate with AI consulting companies and firms specializing in artificial intelligence consulting. AI in healthcare improves risk stratification and identifies high-cost members, enhancing outcomes and reducing costs. 

Reference url

Recent Posts

lenacapavir HIV PrEP access
    

Global Health Partnerships Unite to Expand Access to Lenacapavir for HIV Prevention

💉 How can we ensure equitable access to HIV prevention methods like lenacapavir?

A recent initiative from the Global Fund, supported by key global health organizations, aims to provide affordable access to this new HIV pre-exposure prophylaxis medication.

With a goal to reach 2 million individuals over three years, this coordinated effort seeks to drastically cut HIV infections and align with our commitment to ending AIDS by 2030.

Explore the details of this impactful collaboration and how it could transform HIV prevention.

#SyenzaNews #globalhealth #HealthcareInnovation #MarketAccess

antimicrobial resistance africa
     

Africa’s Health Crisis: Antimicrobial Resistance and Mpox Outbreak

🌍 Are we prepared to tackle the hidden pandemic of antimicrobial resistance (AMR) in Africa?

With AMR rapidly becoming a dominant health crisis, it’s critical to understand its impact on our healthcare systems and most vulnerable populations.

The Africa CDC highlights the urgent need for substantial investment and coordinated responses to combat this escalating threat, alongside the ongoing Mpox outbreak.

Discover the pressing challenges and potential solutions in our latest article.

#SyenzaNews #GlobalHealth #HealthcareInnovation #AntimicrobialResistance #PublicHealth

BioSapien cancer drug delivery
    

BioSapien Innovative Cancer Drug Delivery Solutions

🌟 How is innovation in drug delivery shaping the future of cancer treatment? 🌟

Discover how UAE-based BioSapien is transforming the healthcare landscape with the MediChip™ platform, securing $5.5 million in pre-Series A funding to enhance cancer care.

This innovative solution promises to minimise side effects and improve treatment outcomes for patients, fully embracing the potential of biotechnology in the fight against cancer.

Read more about BioSapien’s journey and its impact on global health!

#SyenzaNews #biotechnology #oncology #innovation #HealthTech

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

© 2024 Syenza™. All rights reserved.